Takatoshi Enomoto

Suita, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis.

Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis.

Journal: Briefings in bioinformatics

Published: November 23, 2025

Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.

Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.

Journal: Journal of translational medicine

Published: May 02, 2025

NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

Journal: International journal of molecular sciences

Published: January 06, 2025

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.

Journal: The journal of allergy and clinical immunology. Global

Published: September 10, 2024

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.

Journal: Respiratory research

Published: August 23, 2024

SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.

SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.

Journal: JCI insight

Published: November 28, 2023

Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.

Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.

Journal: The Journal of allergy and clinical immunology

Published: April 04, 2023

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19.

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19.

Journal: Inflammation and regeneration

Published: October 14, 2022

Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer.

Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 22, 2022

Limitations of End-Tidal CO2 Measured with a Portable Capnometer to Estimate PaCO2 for Patients with Respiratory Disease.

Limitations of End-Tidal CO2 Measured with a Portable Capnometer to Estimate PaCO2 for Patients with Respiratory Disease.

Journal: Turkish thoracic journal

Published: February 03, 2022

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

Journal: Nature communications

Published: December 14, 2021

Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab.

Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab.

Journal: Thoracic cancer

Published: November 28, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026